Cibisatamab Biosimilar - Research Grade

In stock
Only %1 left
SKU
ICH5041
Add to Compare
$357.00

Cibisatamab Biosimilar - Research Grade

Product Benefits:

ichorbio’s Cibisatamab Biosimilar for Research Use Only (RUO)

Target:

CEA/CD3

Size:

ichorbio’s Cibisatamab Biosimilar is available in the following sizes: 1mg, 5mg, 10mg, 20mg

Other names:

Carcinoembryonic Antigen

Host:

CHO cells

Species Reactivity:

Human

Specificity:

Detects human CEACAM5.

Purification Method:

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Concentration:

5mg/ml

Formulation:

Sterile, preservative-free, solution in PBS. BSA and Azide free.

Purity:

>95% by SDS-PAGE

Endotoxin:

≤ 1.0 EU/mg as determined by the LAL method

Storage:

This antibody is stable for at least 4 weeks when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at – 20°C or -80°C. Avoid repeated freeze thaw cycles.

Applications:

Functional Assays

Application Notes:

This biosimilar is strictly for research use only (RUO).

More Information
Concentration 9.37mg/ml
Isotype Human IgG1-kappa/lambda with domain crossover, trivalent
Use Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Application Notes This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Applications Functional Assays
Storage This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Endotoxin ≤ 1.0 EU/mg as determined by the LAL method
Purity >90% by SDS-PAGE
Formulation Sterile, preservative-free, solution in PBS. BSA and Azide free.
Purification Method This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Specificity Detects human CEACAM5. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Cibisatamab.
Species Reactivity Human
Target CEA + CD3
Shipping Conditions Blue ice
Other names Carcinoembryonic Antigen
Buffer ICH3002
Sequence https://www.imgt.org/mAb-DB/
Write Your Own Review
You're reviewing:Cibisatamab Biosimilar - Research Grade
Your Rating
Back to Top